You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 19, 2024

FINASTERIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for finasteride and what is the scope of patent protection?

Finasteride is the generic ingredient in five branded drugs marketed by Accord Hlthcare, Actavis Totowa, Actavis Totowa Teva, Alkem Labs Ltd, Aurobindo Pharma, Aurobindo Pharma Ltd, Cipla, Dr Reddys Labs Inc, Dr Reddys Labs Ltd, Gedeon Richter Usa, Hetero Labs Ltd Iii, Ivax Sub Teva Pharms, Mylan, Sun Pharm, Teva, Zydus Pharms Usa Inc, Organon, Blue Water Biotech, and Zydus, and is included in twenty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for finasteride. Thirty-four suppliers are listed for this compound.

Drug Prices for FINASTERIDE

See drug prices for FINASTERIDE

Drug Sales Revenue Trends for FINASTERIDE

See drug sales revenues for FINASTERIDE

Recent Clinical Trials for FINASTERIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Follicle Pharma LtdPhase 1
Mohammed Abd El Mawgoud AmerN/A
Vanderbilt University Medical CenterPhase 2

See all FINASTERIDE clinical trials

Pharmacology for FINASTERIDE
Medical Subject Heading (MeSH) Categories for FINASTERIDE

US Patents and Regulatory Information for FINASTERIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Totowa Teva FINASTERIDE finasteride TABLET;ORAL 077914-001 Mar 28, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms Usa Inc FINASTERIDE finasteride TABLET;ORAL 078900-001 Dec 28, 2009 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva FINASTERIDE finasteride TABLET;ORAL 076511-001 Dec 15, 2006 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Organon PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for FINASTERIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ⤷  Sign Up ⤷  Sign Up
Organon PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ⤷  Sign Up ⤷  Sign Up
Organon PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ⤷  Sign Up ⤷  Sign Up
Organon PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.